Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05368506
Title ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Age Groups: adult | senior
Covered Countries

No variant requirements are available.